Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study for the Symptomatic Treatment of Seasonal Allergic Rhinitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients of either sex between 12 and 70 years of age.~* Patients with documented clinical history of SAR, for at least 2 years prior to the study inclusion.~* Positive skin prick test for at least one of the seasonal allergen specific of the geographical area.~* A previous positive Prick test, or a positive IgE Test (RAST) may also be accepted for inclusion, if performed within 12 months prior to the inclusion.~Exclusion Criteria:~* Patients who have non-allergic rhinitis (vasomotor, infectious, drug-induced, etc.).~* Negative skin prick test (as defined in point 6.1.1.).~* Patients with nasal polyps or a significant deviation of the nasal septum as judged by the investigator as well as nasal intervention in the previous 6 months. Any other nasal illness that can interfere with the aim of the study.~* Patients who have acute or chronic sinusitis as judged by the investigator.~* Patients who have received anti-allergy immunotherapy in the previous two years or are still receiving this kind of therapy.~* Patients who are taking or have taken specified medications prior to randomisation in the study and have not complied with the specified washout period

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): Bilastine
- B (Type: ACTIVE_COMPARATOR): Cetirizine
- C (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).